Shanghai Beshining Law Office was founded in 2013 by main partner Xue Qi and his team from Shanghai Zhixin Patent Agent Ltd., and its headquarters is located in Shanghai.

As one of the few leading law offices authorized to engage in patent and trademark, we currently house nearly one hundred personnel including lawyers, patent attorneys, trademark attorneys, and other legal and technical professionals with diverse background and expertise.

We have 16 lawyers and 38 patent attorneys who are in the fields of Chemistry, Pharmaceuticals and Biology .Our firm enjoys a patent grant rate of over 90% for invention in such areas. Our clients cover hundreds of domestic and foreign large and medium Generic Drug Manufacture Companies, New Drug R&D companies, Pharmaceutical R&D Outsourcing Companies, Pharmaceutical Investment Companies, Universities, R&D institutes, Start-ups and so on. We have provided for those companies with full IP legal services, including domestic and foreign patent/trademark application, patent/trademark invalidation, patent/trademark litigation, patent FTO analysis, IP Due diligence and so on. Our team was awarded the title of Outstanding IP Service Team in China (2015) by China IP Magazine and China Daily IPR Channel.

Contact Us

21st Floor SFECO Mansion 681 Xiaomuqiao Road, Shanghai 200032, P.R.China

TEL: 86-21-51797188

FAX:86-21-51797166

EMAIL: law@beshininglaw.com

Website: www.beshininglaw.com

Classic Cases

1. In the patent invalidation case against Takeda Pharmaceutical Company Limited in Japan, our agency represented the patent invalidation petitioner Yongning Pharma in Zhejiang province and eventually won the Retrial (held by Supreme People’s Court) after 6 years’ battle.

Meantime, our agency also helped Yongning Pharma win the battle in field of patent infringement litigation raised by Takeda Pharmaceutical Company Limited.

2. In the patent infringement litigation raised by Royal DSM (Fortune 500) , our agency represented the defendant Shanghai Sykesion Materials Technology Co. Ltd, helped our client won the patent infringement litigation case, in which the Royal DSM had claimed 1 million Euro for compensation, and invalidated the patent concerned (patent number: CN200780033118.2) in whole.

3. Our agency carried out global FTO survey of preclinical new drug compounds for a Shanghai pharmacy company to exclude infringement risk.